Search
Peer-Reviewed Publication
Antibiotic resistance in Europe: the challenges ahead
Monnet, D.L., Suetens, C., Buksarova, A., Earnshaw, S., Gagliotti, C., Heuer, O., Magiorakos, A.P., Mantero, J., Marma, S., Navarro, Torne, A., Sodano, L., Weber, J.T., Weist, K.
Publication
European surveillance of Clostridium difficile infections - surveillance protocol version 2.3
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
Peer-Reviewed Publication
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Ricchizzi, E., Latour, K., Kärki, T., Buttazzi, R., Jans, B., Moro, M.L., Nakitanda, O.A., Plachouras, D., Monnet, D.L., Suetens, C., Kinross, P., The Halt Study Group
Publication
European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4
ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Peer-Reviewed Publication
A governance framework for development and assessment of national action plans on antimicrobial resistance
Anderson, M., Schulze, K., Cassini, A., Plachouras, D., Mossialos, E.
Peer-Reviewed Publication
Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012
Zacher, B., Haller, S., Willrich, N., Walter, J., Abu Sin, M., Cassini, A., Plachouras, D., Suetens, C., Behnke, M., Gastmeier, P., Wieler, L.H., Eckmanns, T.
News
US CDC report on antibiotic resistance threats in the United States, 2013
Antimicrobial resistance represent a serious threat to public health and patient safety and is a worldwide problem. Each year, in the European Union (EU) at least 25 000 patients die of infections with multidrug-resistant bacteria.